BELKYRA™ Deoxycholic Acid Injectable Toronto
Reduce Unwanted Fat Under the Chin
BELKYRA™ Deoxycholic Acid Injectable reduces submental fat, better known as a double chin. Deoxycholic Acid Injectable is a safe, non-invasive, non-surgical treatment that has become a popular treatment for patients who want to improve their profile and define their jawline.
What is BELKYRA™ and Deoxycholic Acid Injectable?
BELKYRA™ contains deoxycholic acid, a naturally occurring bile acid molecule that dissolves fat. When injected into the submental fat, Deoxycholic Acid Injectable safely and permanently destroys fat cells. Deoxycholic Acid Injectable is the first injectable approved by Health Canada to permanently remove submental fat.
Compass Dermatology has offered Deoxycholic Acid Injectable since its approval by Health Canada in 2016. Every Deoxycholic Acid Injectable treatment is performed by our highly experienced board-certified dermatologists.
Why Choose Compass Dermatology for Your BELKYRA™ Treatment
Every treatment is performed by experienced, board-certified dermatologists, rather than nurses or technicians working independently. Our dermatologists have extensive experience with Belkyra injections, minimizing risk through precise injection technique and comprehensive pre-treatment assessment. They will thoroughly review your medical history to identify any contraindications before proceeding with treatment.
Precision and Artistry
We don't just reduce fat; we sculpt refined, natural-looking jawlines that complement your unique facial features.
Comprehensive Approach
We assess whether Belkyra alone will achieve your goals, or if combining treatments (like Ultherapy or dermal fillers) will deliver superior results.
Transparent Communication
We set realistic expectations from your first consultation through your final result.
Who is a Candidate for Treatment with Deoxycholic Acid Injectable?
Deoxycholic Acid Injectable is an effective treatment for removing unwanted fat from the chin and jawline, resulting in a more defined lower face and profile. It may be used as a stand-alone treatment or following submental Cryolipolysis Non-Invasive Fat Removal if there is a more significant amount of fat. You will be assessed by one of our board-certified dermatologists to determine your optimal treatment plan.
Studies show that Deoxycholic Acid Injectable does result in some tightening of the skin, but patients with a predominance of lax skin are often better candidates for surgical intervention.
The only way to know if you are a candidate for Deoxycholic Acid Injectable is to visit our practise for a consultation.
Sign up to win free products & treatments every month
Take control of your look
Our Comprehensive Approach to Deoxycholic Acid Injectable
Deoxycholic Acid Injectable is injected into the fat along the jawline and under the chin in a grid pattern, with injections approximately 1 cm apart. There is commonly a stinging sensation associated with injection of Deoxycholic Acid Injectable. You are able to resume normal activities the day following your treatment. There may be bruising and swelling following injection of Deoxycholic Acid Injectable, but these resolve within two weeks.
Deoxycholic Acid Injectable is administered as series of three to five treatment sessions, typically spaced 4 to 8 weeks apart.
Results are evident 4-6 weeks following treatment.
What to Expect After Treatment
The First 48 Hours:
Swelling is your body's natural response as it begins breaking down fat cells. This is actually a sign that Belkyra is working. You may experience numbness, tenderness, or firmness under the chin. These sensations gradually subside within days.
Week 2-4:
As swelling diminishes, you'll start noticing subtle changes in your profile. The full results emerge gradually as your body naturally processes and eliminates the destroyed fat cells through your lymphatic system. This progressive transformation ensures a natural-looking outcome." Individual results vary based on the amount of submental fat and your body's response to treatment. During your consultation, our dermatologists use their clinical expertise to set realistic expectations and create an effective treatment plan that is designed to achieve your unique aesthetic goals. The key to success is patience. As Belkyra breaks down the fat cells and your body naturally eliminates them, your results will emerge gradually for a natural, lasting transformation.
The determining factors are the amount and location of submental fat, skin quality, and your overall health. A personalized consultation is the only way to determine if Belkyra aligns with your needs.
Real Results: What Can Belkyra Achieve?
Belkyra delivers meaningful, measurable improvements in chin contour. Clinical studies demonstrate that patients experienced a significant reduction in submental fullness, with results visible as early as 4 weeks after treatment. More importantly, patient satisfaction rates remain high, with many reporting improved self-confidence and enhanced facial profile.
The transformation goes beyond physical changes. Many patients describe feeling more photogenic, more comfortable in professional settings, and more confident during video calls, which is an increasingly important consideration in our digital-first world!
The Journey from Science to Solution
The story of Belkyra begins not in an aesthetic clinic, but in the human digestive system. Scientists have long known that deoxycholic acid (a bile acid molecule naturally produced by our bodies) plays a crucial role in breaking down dietary fat during digestion. This biological function sparked an innovative question: Could this natural substance be harnessed to target unwanted fat deposits?
In the early 2000s, researchers at Kythera Biopharmaceuticals began investigating synthetic deoxycholic acid as a potential fat-reduction treatment. Years of rigorous clinical trials followed, involving over 2,600 patients across multiple studies. The results were compelling: when injected into submental fat, deoxycholic acid safely and permanently destroyed fat cells without surgery.
Regulatory Milestones
In April 2015, the FDA made history by approving Kybella (the US brand name), marking the first, and still only, injectable treatment specifically authorized for reducing submental fullness. The following year, Health Canada granted approval in 2016, releasing it to the Canadian market as Belkyra.
For the first time, patients bothered by their double chin had a proven, non-surgical alternative to liposuction that required no general anesthesia, no incisions, and minimal downtime.
Since its approval, Belkyra has transformed thousands of profiles worldwide. Its success validated the concept of injectable fat reduction and paved the way for continued innovation in non-surgical body contouring. Today, Belkyra stands as the gold standard for injectable treatments targeting a double chin, offering effective results without the need for surgery.
For those who prefer a non-invasive alternative without injections, CoolSculpting provides another excellent nonsurgical option.
Why Choose Belkyra Over Surgery?
For years, liposuction was the only solution for stubborn submental fat. Today, Belkyra offers a non-surgical alternative that fits seamlessly into your lifestyle. Unlike surgery, there's no general anesthesia, no scalpels, and no extended downtime.
While surgical procedures require careful planning around recovery time, Belkyra treatments can be scheduled to fit your busy schedule. This discreet transformation appeals to patients who value subtlety and convenience without compromising effectiveness.
Deoxycholic Acid Injectable Belkyra FAQ
What is Deoxycholic Acid Injectable?
Deoxycholic Acid Injectable is the first injectable authorized by Health Canada for treatment of submental fat. It contains deoxycholic acid, a naturally occurring bile acid molecule that dissolves fat.
How long does Deoxycholic Acid Injectable last?
How many sessions of Deoxycholic Acid Injectable are required?
Is Belkyra painful?
Can Belkyra be combined with other treatments?
Is Belkyra Safe? Side Effects and Risks
Belkyra has been extensively studied and is approved by Health Canada and the FDA (in the US, it is called Kybella). Clinical trials involving thousands of patients demonstrated its safety profile, but only when administered by qualified medical professionals like our board-certified dermatologists.
What causes a double chin?
Do fat dissolving injections really work?
Does Deoxycholic Acid Injectable tighten skin?
In the Media
650 Mount Pleasant Rd #8
Toronto, ON M4S 2N5, Canada
Phone: 647-351-9277
Fax: 647-351-9077
Get social